Scientific Program

Conference Series Ltd invites all the participants across the globe to attend Global Summit on Neurology and Neurosurgery Lisbon, Portugal.

Day 2 :

  • Neurosurgery conference
Location: Holiday Inn Lisbon Continental

Sandra Sungailaite, The James Cook University Hospital, UK



The objective of the study is to look for the effectiveness of percutaneous  balloon kyphoplasty in the restoration of Vertebral body  height  and correction or improvement of kyphosis .


Retrospective study.


Patients  with Vertebral column wedge  compression fracture.


A retrospective  analysis of  112 patients presented  over 4  years and 4 months with 200  symptomatic  wedge vertebral compression fractures treated by Percutaneous  balloon Kyphoplasty. To assess  degree of kyphosis  and height restoration of  fractured  vertebral  body , we reviewed  digital radiographs  and measured  pre  and post cobb and wedge angle for  kyphosis ; Ratios of the height of the anterior border, centre, and posterior borders of the collapsed vertebra to the height at the posterior border of an adjacent normal vertebral body were measured in  immediate post-operative period  and next follow up   and also  calculated  gain of  height in anterior , middles and posterior  part of  Vertebral body, percentage of lost height restoration.


The height of vertebral body height increases after  kyphoplasty. The anterior body height  improved  10%  in first post-operative and subsequently 14% in next follow up . Middle and posterior heights also revealed  13%, 17% and 9% , 11% improvement  respectively.  The restoration percentage for the  lost vertebral height were 34 % for anterior  border in the first  Post operative  period , 49%  in the next  out patient follow up; 46%  and 60% for middle border, and  62%, 76% for posterior  border of vertebral  height. The  mean reduction  in kyphotic angle  was 3.1 degree, and  2.4 degree in wedge angle, restoration percentages for the kyphosis angle and wedge angle were 11.3%  and 18.7%, respectively.


Kyphoplasty result in  improvement of height of vertebral body and angular deformity .


Dr. Rahul Hajare has been a hard worker all his academic life. After his Ph.D in Pharmacy from VMRF Salem which he completed with flying colours, he is fortunate to work NARI primer HIV research Institute to complete Post Docunder the of World Renowned Scientist Respected Dr. R.S.Paranjape., Retired Director & Scientist ‘G’ National AIDS Research Institute Pune. Dr. Rahul Hajare has Associate Professor of Pharmaceutical Medical Chemistry to Pune University (until 2020), he has serviced three times AssociateProfessor in Pharmaceutical Science and Analytical Science. Graduated from Amravati University in 2003, after an assignment he worked as an M.Pharm Scholar in the Institute of Pharmaceutical Education and Research passed with distinction, he has Post Graduate Teacher for Master of Pharmacy, he has more than 30 scientific and methodological works, 3 patents of scientific research.


Colleagues finish a task at work can be draining, even leading to poor performance. Helping your co-workers too often may lead to mental and emotional exhaustion and hurt your job performance; a new study has come out form less sunlight pharmacy Institutions in reputed Amravati university. The effects has especially strong for employees with high "pro-social motivation" or those who care deeply about the welfare of others, researchers from Amravati University seen.While a previous study on helping has focused largely on the effects of the beneficiaries, this has one of the first studies to focus on the helpers, they said."Helping co-workers can be draining for the helpers, especially for employees who help a lot. Somewhat ironically, the draining effects of helping are worse for employees who have high pro-social motivation. When these folks are asked for help, they feel a strong obligation to provide help, which can be especially taxing.

Osama Elshahawy

Cairo University Hospitals, Egypt

Title: Intracranial Childhood Meningiomas

Cairo University Hospitals, Egypt


Childhood meningiomas are uncommon and their characteristics differ from those commonly found in adults. Over the 7-years period from 1992 to 1998 five cases of histopathologically proven meningiomas are discussed as regards clinical presentation, age and sex, site, size, presence of cysts, histological nature and operative management. There were three males and two females, ages ranging from 7 months to 12 years. All cases presented within seven months of clinical symptomatology. The most common presentation being raised intracranial pressure followed by seizures. Three were located supratentorially and two in the posterior fossa. They all showed bright tumour enhancement and were large (>5 cms in diameter). There were no postradiation or intraventricular tumors in our series. One of our cases revealed the importance of CT scanning in conjunction with MRI in cases where meningioma is suspected and presented valuable preoperative information. It showed a hyerostosing reaction, which MRI failed to demonstrate. There was one case each of meningothelial, transitional, round cell, atypical and vascular meningioma. Where the tumor could not be totally removed along with basal dural attachment recurrence occurred in less than 8 months. One case died due to postoperative pulmonary complications. Two cases received postoperative irradiation


OGUEJI, Ifeanyichukwu Anthony. "Clinical Psychology in Nigeria: An Assessment of Perceptions of the Growing Subfield Among Non-Mental Health Professionals And Recommendations For Growth Acceleration.


Background: One area of substance abuse among adolescents that has not been fully understood in the Nigerian context is the attitude of adolescents towards cough syrup abuse, as most related studies were either focused on attitude towards general substance abuse or substances other than cough syrup.

Objective: The main objective of this research explored the attitudes of adolescents towards cough syrup abuse in Southwest Nigeria.

Methods: By a stratified sampling method, 302 participants (152 males, 150 females; mean age=13.61 years, SD=2.09) were selected from secondary schools in Oyo state and Lagos state, Nigeria, and data were collected using standardized questionnaires. Guided by literature review, four hypotheses were stated and tested using t-test and correlation statistics.

Results: Findings indicated that male and female adolescents did not significantly differ in their attitude towards cough syrup abuse (t=-16.68; DF=300; P>.05). Further results showed that, there was a significant positive relationship between adolescents’ age and their attitude towards cough syrup abuse (r=.21; DF=300; P<.01). Another result showed that, adolescents from polygamous family reported significantly higher positive attitude towards cough syrup abuse than their counterparts from monogamous family (t=-18.98; DF=300; P<.05). The last finding showed that adolescents in Oyo state and Lagos state did not significantly differ in their attitude towards cough syrup abuse (t=.03; DF=300; P>.05).

Conclusion: Adolescents’ age and family marital structure are the variables found in this research that significantly accounts for their attitude towards cough syrup abuse, thus, it is imperative enough that as adolescents are growing older, they are rightly guided against giving into substance abuse. Also, parents/caregivers of adolescents need to be actively involved in educating adolescents on the hazards associated with substance abuse.


Leslie A McCallum has completed her PhD at the Factor-Inwentash Faculty of Social Work in 2019. She also holds a Master of Social Work from the University of Toronto and a Bachelor of Commers (honours) from Queen’s University. She is a Director of Research and Program Evaluation at Cedar Centre (part-time), a mental health agency that treats individuals with childhood interpersonal trauma, and a Research Associate at the University of Toronto. Prior to entering the PhD program, she was as a Senior Executive in Communications and Marketing, working for a wide range of clients, including several mental health organizations.


Anorexia nervosa (AN) is a complex, life-threatening mental illness with high comorbidity rates. This disorder has one of the worst prognoses of all mental illnesses, with a mortality rate of 10.5%. It affects people of varying socioeconomic statuses, cultures, sexes, genders, and ages. There is no universally effective treatment for adults living with AN. Despite the high percentage of individuals who continue to live with AN for decades, there is limited understanding of what it means to be in midlife living with a disorder that is more commonly noted to occur among adolescents and young adults. This was a qualitative study using constructivist grounded theory methodology. This research was conducted in accordance with the ethics protocol approved by the Health Sciences Research Ethics Board of the University of Toronto. Nineteen individuals in midlife (40 to 65 years of age) living with AN participated in individual, in-depth interviews. Four main findings emerged from this study. First, important differences exist between livings with AN in midlife versus when one is younger. Second, based on this sample and their retrospective accounts, complex trauma is common among individuals in midlife living with AN. Third, midlife can act as a barrier to seeking treatment and/or facilitate disengaging from treatment. Fourth, shifts occur in midlife that can act as catalysts to fully engaging in recovery. Honoring the added challenges that come with midlife, as well as harnessing qualities developed in midlife will help this older age group move forward with their recovery journey, moving from feeling hopeless to feeling hopeful.


Seyed Raheleh Ahmadian currently works at the Cellular and Molecular Biology Research Center, Babol University of Medical Sciences. Seyed Raheleh does research in Molecular Biology, Cell Biology and Neuroscience. Their most recent project is ' Effect of ZnO nanoparticles on expression of inflammatory  genes, learning function and spatial memory

I have completed my MSc at the age of 27 years from Babol University of Medical Sciences. Now I am flow cytometer Operator in cellular and molecular biology research center, Health Research Institute, Babol University of Medical Sciences. He has published 6 papers in reputed journals and 9 impress articles.


Introduction: Epilepsy is one of the most common chronic neurological disorders, which provoke progressive neuronal degeneration and memory impairment. In recent years, application of herbal compounds with anti-inflammatory properties, such as ursin has been introduced as useful agent in reducing of the epilepsy symptoms. In this study, the effect of ursin application on spatial memory improvement, neuronal density and astrocyte activation were evaluated in pentylenetetrazol (PTZ)-induced kindling model.

Method and material: Male NMRI mice have received the daily injection of ursin at dose of 25 and 50 mg/kg. All interventions were injected intraperitoneally (i.p.), 10 days before PTZ administration and the injections were continued until 1 h before each PTZ injection. Spatial learning and memory was evaluated using Morris water maze test after the 11th PTZ injection. Animals have received 13 injections of PTZ and then, brain tissues were removed. Immunostaining against NeuN and GFAP respectively as mature neuronal and astrocyte markers were performed on brain sections. High performance liquid chromatography (HPLC) was performed to measure the ursin content in hippocampus.

Result: Our results showed that ursin administration reduced the seizures behavior and prevented cognitive impairment in fully kindled animals. The results of HPLC analysis showed that high amount of ursin can be detected in hippocampus of ursin+PTZ receiving animals. Immunostaining data demonstrated that the level of neuronal loss and astrocyte activation were reduced in animals under treatment of ursin.

Conclusion: Overall, the results of this study suggest that ursin administration effectively ameliorates memory impairment and alleviates the level of neuronal death and astrocyte activation in PTZ-induced kindling model.


Jessica Barnes graduated from Worcester Polytechnic Institute with a B.S. in Biotechnology, and earned her PhD in Molecular Neuroscience from the University of Illinois at Urbana-Champaign. She was a fellow in the department of pediatric neuro-oncology at the Dana-Farber Cancer Institute and Children’s Hospital Boston under the mentorship of Dr. Judah Folkman. Her roles have including CEO/Co-founder of the 20Lighter Program, Director of New Ventures at Access BridgeGap Ventures, Senior Science Officer at Summer Street Research Partners, and Vice President in MEDACorp at Leerink Swann. Additionally, she provides Business & Corporate Development consulting services to biotech & med device companies.


Treatment of advanced Parkinson’s disease (PD) remains challenging, with fluctuations in motor status often resulting in patients becoming severely handicapped1. The short-acting dopamine D1/D2 receptor agonist, Apomorphine (Apo), was the first dopamine receptor agonist used to treat PD2. The magnitude and pattern of the motor response to single dose of subcutaneously administered Apo is qualitatively comparable to that of oral levodopa, however side effects (nausea, vomiting, etc.) can be problematic3. Close to a dozen clinical studies have shown subcutaneous Apo infusions are successful in aborting ‘off’ periods, reducing dyskinesias and improving PD motor scores with the added benefit of a substantial levodopa-sparing effect2. However, bulky infusion pumps requiring delivery of relatively large volumes remain a barrier to development of therapeutic products that are patient (and caregiver) friendly. We investigated the pharmacokinetics (PK) of Apo delivered over a single 24-hour period using the wearable h-Patch™ subcutaneous infusion device in dogs. Apo (10mg) was delivered with PK evaluated at time points to 48h from the start of infusion. Apo levels were detectable in blood detected within two hours of the beginning of infusion and gradually dropped off after completion of h-Patch™ infusion (24h). With additional work on a concentrated Apo solution and modest expansion of the h-Patch reservoir, the wearable

h-Patch represents a patient friendly subcutaneous delivery mechanism for Apo providing the benefits of a full 24h infusion of low dose Apo to eliminate ‘off’ periods and improve motor status without tolerability issues seen with subcutaneous injections.

Ramachandran Muthiah

Zion hospital, Azhagiamandapam, Kanyakumari District, India

Title: “Brain abscess” in Cyanotic Heart Disease

Published many papers in Cardiosource, American College of Cardiology Foundation, Case Reports in Clinical Medicine (SCIRP) and Journal of Saudi Heart Association. Special research on Rheumatic fever and Endomyocardial fibrosis in tropical belts, Myxomas, Infective endocarditis, apical hypertrophic cardiomyopathy, Ebstein’s anomaly, Rheumatic Taussig-Bing Heart, Costello syndrome and Tetralogy of Fallot.


Brain abscess is an intraparenchymal infection of brain parenchyma and begins with a localized area of inflammatory change referred to as ‘cerebritis’, progress to immature capsule stage and then to abscess, containing pus encapsulated by a vascularized membrane. The capsule serves to prevent the infective process from becoming generalized and it also create within it an inflammatory “soup” that may impede resolution of the infection. The incidence of brain abscess is about 8% of intracranial masses in developing countries and in cyanotic heart disease, its incidence varies from 5 to 18.7%. In patients with right-to-left shunts, absence of pulmonary phagocytic clearance of pathogens can occur and the ischemic injury from hypoxaemia and polycyathaemia, produce low perfusion areas in the brain which may act as a nidus for infection and anaerobic streptococci are the most common agents isolated in cyanotic heart disease with brain abscess. All abscesses > 1 cm produce positive scans and CT brain appears to be adequate in most cases of brain abscess. Third generation cephalosporins (cefotaxime or ceftriaxone) combined with metronidazole for 2 weeks followed by 4 weeks of oral therapy is the medical treatment of choice for cyanotic brain abscess. Surgical techniques such as drainage via burr-hole, complete excision after craniotomy, migration technique and neuroendoscopic technique with freehand stereotaxy  have also been practiced in the treatment of brain abscess.